HSHana Bashir Shawish

Hana Bashir Shawish

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hana Bashir Shawish has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thermodynamic Studies of Co(II) Complexation with Schiff Base Ligands in Different Nonaqueous Solvents

    by Khaled Muftah Elsherif, Abdulfattah Mohamed Alkherraz, Hana Shawish, Salima Abajja, Awatif Al-Arbash

    This study investigates the synthesis and characterization of two novel Schiff base ligands, L1 and L2, and their complexation behavior with Co(II) ions in non-aqueous media. Ligand L1 was synthesized using o-hydroxyacetophenone and salicylaldehyde with ethylenediamine, while L2 was prepared with 2,3-dihydroxybenzaldehyde and ethylenediamine. Conductometric measurements in ethanol, acetonitrile, and a 1:1 mixture of these solvents at temperatures ranging from 25°C to 40°C determined the stability constants of the Co(II) complexes. Results showed distinct temperature-dependent stability trends: L1 complexes decreased in stability with increasing temperature in all solvents, indicating exothermic reactions, while L2 complexes showed varied behavior, suggesting endothermic reactions in acetonitrile and the mixed solvent. The solvent environment significantly influenced complex stability, with acetonitrile showing the highest stability, followed by the 1:1 solvent mixture and ethanol. L2 exhibited higher stability constants than L1, attributed to additional hydroxyl groups in L2 enhancing Lewis basicity, while the methyl group in L1 caused steric hindrance, reducing stability. Thermodynamic analysis revealed negative ΔG° values (-27.9 to -32.1 kJ/mol) for all reactions, indicating spontaneity. Enthalpy changes (ΔH°) varied, with negative values (-27.6 to -195 kJ/mol) for exothermic and positive values (7.37 and 42.3 kJ/mol) for endothermic reactions. Entropy changes (ΔS°) varied, reflecting differences in molecular organization and solvent-ligand interactions. This study provides insights into factors affecting metal-ligand complexation in non-aqueous environments, with implications for designing coordination compounds for various applications in chemistry

  • Synthesis and Experimental Structure of a Multifunctional Catechol‐Azomethinebenzoic Acid, DFT/DMol 3 Calculations, and Molecular Docking with Hsp90

    by Hana Bashir Shawish, Hela Ferjani, Ismail Taban, Meftah Salah Gasibat, Eman Bashir Al‐Melah, Sascha A. Schäfer, Chahra Amairia, Waqar Saleh Abuzwaida, Yassmin Ali Alshawish, Axel Klein

    The multifunctional catechol‐azomethine‐benzoic acid derivative 4‐[( E )‐[(2,3‐dihydroxyphenyl)methylidene]amino]benzoic acid ( 1 ) was prepared and the structure were confirmed by EI‐MS and 1 H and 13 C NMR spectroscopy. A Single‐crystal X‐ray diffraction study revealed coplanarity of the two aromatic rings within the imine function, supported by intramolecular N−H⋯O hydrogen bonds. In the crystal structure intermolecular O−H⋯O hydrogen bonds form chains, propagating along [010]. FT‐IR and Hirshfeld surface analysis confirms the multiple hydrogen bonding. DFT/DMol 3 calculations localized the highest occupied molecular orbital (HOMO) on the o ‐catechol unit, while the lowest unoccupied molecular orbital (LUMO) is delocalized over the entire molecule. The calculated map of electrostatic potential (MEP) showed relatively low values for both electrophilic and nucleophilic susceptibility. A molecular docking study of 1 in comparison with the established inhibitor geldanamycin ( G ) using the protein structure of the heat shock protein 90 co‐crystallized with G (Hsp90⋅ G ) showed that 1 occupies the same binding pocket as G in the Hsp90⋅ G structure, indicating that the title structure might be a suitable inhibitor. The Swiss ADME approach showed promising general drug‐likeness properties for 1 with a relatively high lipophilicity (logP=1.68) and a logS value of −2.99 which lies in the middle of the logS distribution of traded drugs.